VIM and hepatocellular carcinoma: Altogether, our study provides evidence that measuring methylation levels of VIM and FBLN1 in plasma cfDNA may be effective for biomarker-based detection and follow-up of HCC, contributing to novel strategies for improved diagnosis accuracy and patient surveillance.